Table 3.
Transplant-related characteristics of the ‘livers that nobody wants’ (LNW) (n = 26) and control (n = 25) groups
| LNW group | Control group | P-value | |
|---|---|---|---|
| Median recipient age, years (range) | 60 (21–73) | 56 (20–69) | 0.68 |
| Gender, male/female, n | 13/13 | 19/6 | 0.10 |
| Diagnosis (HCV/alcohol/other), n | 8/8/10 | 8/7/10 | 0.97 |
| Hepatocellular carcinoma, n (%) | 7 (26.9) | 7 (28) | 0.89 |
| Median time in our LT programme, days (range) | 53 (1–696) | 42 (1–788) | 0.72 |
| Median position on the waiting list (range) | 71 (31–432) | 18 (2–29) | <0.001 |
| Median MELD score (range) | 13 (6–21) | 18 (6–34) | 0.02 |
| Median corrected MELD score (range) | 13 (6–21) | 22 (7–34) | <0.001 |
| Donor risk factors (≤2 vs. 3–4 factors) | 11/15 | 19/6 | 0.03 |
MELD scores were calculated at the time of transplantation with and without correction for patients with hepatocellular carcinoma according to the United Network for Organ Sharing (UNOS)
HCV, hepatitis C virus; LT, liver transplant, MELD, Model for End-stage Liver Disease